Skip to main content
. 2018 Oct 1;15(10):e1002666. doi: 10.1371/journal.pmed.1002666

Fig 2. Cumulative relative survival of invasive cervical cancer cases by tumor high-risk human papillomavirus (hrHPV) status.

Fig 2

Cumulative relative survival corresponds to the relative survival ratio in relation to the general female population with comparable age and during the same calendar period over the indicated time since diagnosis. p-Values of a Wald test between hrHPV-positive cases and hrHPV-negative cases are less than 0.001 across time since cancer diagnosis.